Synapse - Andrew D Seidman

Andrew D Seidman

Seidman andrew 1680

Groups

Breast Cancer Disease Management Team
Solid Tumor Oncology Division
- Breast Medicine Service

Research Focus

Medicine; Attending

Recent additions – View all

Phase 2 study of dose-dense doxorubicin and cyclophosphamide followed by eribulin mesylate with or without prophylactic growth factor for adjuvant treatment of early-stage human epidermal growth factor receptor 2–negative breast cancer
Journal Article

Cadoo, K. A.; Kaufman, P. A.; Seidman, A. D.; Chang, C.; Xing, D.; Traina, T. A.
Clinical Breast Cancer (2018)

Fulltext@MSK | Save
National Cancer Institute Breast Cancer Steering Committee working group report on meaningful and appropriate end points for clinical trials in metastatic breast cancer
Journal Article

Seidman, A. D.; Bordeleau, L.; Fehrenbacher, L.; Barlow, W. E.; Perlmutter, J.; Rubinstein, L.; Wedam, S. B.; Hershman, D. L.; Fallas Hayes, J.; Pearson Butler, L.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save
Characteristics and prognostic factors for patients with HER2-overexpressing breast cancer and brain metastases in the era of HER2-targeted therapy: An argument for earlier detection
Journal Article

Morikawa, A.; Wang, R.; Patil, S.; Diab, A.; Yang, J.; Hudis, C. A.; McArthur, H. L.; Beal, K.; Seidman, A. D.
Clinical Breast Cancer (2018)

Fulltext@MSK | Save

Co-authors at MSK

Types of Work

Publications

Journal of Clinical Oncology (59)
Breast Cancer Research and Treatment (18)
Clinical Breast Cancer (18)
Cancer Research (16)
Oncology (Norwalk) (14)
Seminars in Oncology (14)
Annals of Oncology (9)
Clinical Cancer Research (9)
Cancer Investigation (7)
Neuro-Oncology (6)